Found: 25
Select item for more details and to access through your institution.
Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602).
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. 722, doi. 10.1093/oncolo/oyad140
- By:
- Publication type:
- Article
A Novel HRD Signature Is Predictive of FOLFIRINOX Benefit in Metastatic Pancreatic Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. 691, doi. 10.1093/oncolo/oyad178
- By:
- Publication type:
- Article
Reflections on the Financial Toxicity of Cancer: 10 Years Later.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. 654, doi. 10.1093/oncolo/oyad179
- By:
- Publication type:
- Article
Molecular Advances in the Treatment of Advanced Gastrointestinal Stromal Tumor.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. 671, doi. 10.1093/oncolo/oyad167
- By:
- Publication type:
- Article
Mogamulizumab-Associated Myositis With and Without Myasthenia Gravis and/or Myocarditis in Patients With T-Cell Lymphoma.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. e694, doi. 10.1093/oncolo/oyad155
- By:
- Publication type:
- Article
Variations in Genomic Testing in Non-small Cell Lung Carcinoma: A Healthcare Professional Survey of Current Practices in the UK.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. e699, doi. 10.1093/oncolo/oyad134
- By:
- Publication type:
- Article
Prevalence and Predictors of Physician-Patient Discordance in Prognostic Perceptions in Advanced Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. e653, doi. 10.1093/oncolo/oyad098
- By:
- Publication type:
- Article
The Value of Pharmaceutical Industry-Sponsored Patient Registries in Oncology Clinical Research.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. 657, doi. 10.1093/oncolo/oyad110
- By:
- Publication type:
- Article
Less Irradiation to Lymphocyte-Related Organs Reduced the Risk of G4 Lymphopenia in Esophageal Cancer: Re-Analysis of Prospective Trials.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. e645, doi. 10.1093/oncolo/oyad109
- By:
- Publication type:
- Article
Moving the Pendulum for Glioblastoma Treatment: One Injection at a Time.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. 651, doi. 10.1093/oncolo/oyad104
- By:
- Publication type:
- Article
Integration of Multi-omic Data in a Molecular Tumor Board Reveals EGFR-Associated ALK-Inhibitor Resistance in a Patient With Inflammatory Myofibroblastic Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. 730, doi. 10.1093/oncolo/oyad129
- By:
- Publication type:
- Article
Surgical Margin Affects the Long-Term Prognosis of Patients With Hepatocellular Carcinoma Undergoing Radical Hepatectomy Followed by Adjuvant TACE.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. e633, doi. 10.1093/oncolo/oyad088
- By:
- Publication type:
- Article
Bone Metastases Detection in Patients with Breast Cancer: Does Bone Scintigraphy Add Information to PET/CT?
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. e600, doi. 10.1093/oncolo/oyad087
- By:
- Publication type:
- Article
Association Between Lymphopenia and Survival Outcomes in Esophageal Carcinoma Patients Receiving Combined Immunotherapy and Chemoradiotherapy.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. e606, doi. 10.1093/oncolo/oyad094
- By:
- Publication type:
- Article
A 6-Week Program to Strengthen Resiliency Among Women With Metastatic Cancer: A Randomized Clinical Trial.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. e669, doi. 10.1093/oncolo/oyad091
- By:
- Publication type:
- Article
Relugolix in Clinical Practice: The Best Route for All?
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. 647, doi. 10.1093/oncolo/oyad099
- By:
- Publication type:
- Article
Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. e625, doi. 10.1093/oncolo/oyad097
- By:
- Publication type:
- Article
Regulatory Issues: PMDA – Review of Sakigake Designation Products: Oncolytic Virus Therapy with Delytact Injection (Teserpaturev) for Malignant Glioma.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. 664, doi. 10.1093/oncolo/oyad041
- By:
- Publication type:
- Article
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. 714, doi. 10.1093/oncolo/oyad039
- By:
- Publication type:
- Article
Survival After Sentinel Lymph Node Biopsy Compared with Axillary Lymph Node Dissection for Female Patients with T3-4c Breast Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. e591, doi. 10.1093/oncolo/oyad038
- By:
- Publication type:
- Article
HER2 Expression Associated with Clinical Characteristics and Prognosis of Urothelial Carcinoma in a Chinese Population.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. e617, doi. 10.1093/oncolo/oyad070
- By:
- Publication type:
- Article
Real-World Evaluation of Disease Progression After CDK 4/6 Inhibitor Therapy in Patients With Hormone Receptor-Positive Metastatic Breast Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. 682, doi. 10.1093/oncolo/oyad035
- By:
- Publication type:
- Article
Characteristics of Immune Checkpoint Inhibitor-Associated Gastritis: Report from a Major Tertiary Care Center.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. 706, doi. 10.1093/oncolo/oyad031
- By:
- Publication type:
- Article
Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. 737, doi. 10.1093/oncolo/oyad019
- By:
- Publication type:
- Article
A Practical Guide to Relugolix: Early Experience With Oral Androgen Deprivation Therapy.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. 699, doi. 10.1093/oncolo/oyad036
- By:
- Publication type:
- Article